Cargando…
Thromboprophylaxis in COVID-19: Early initiation might be as important as optimal dosing
Autores principales: | Kollias, Anastasios, Poulakou, Garyphallia, Dimakakos, Evangelos, Kyriakoulis, Konstantinos G., Syrigos, Konstantinos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206617/ https://www.ncbi.nlm.nih.gov/pubmed/34144797 http://dx.doi.org/10.1016/j.thromres.2021.06.004 |
Ejemplares similares
-
High versus Standard Intensity of Thromboprophylaxis in Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis
por: Kollias, Anastasios, et al.
Publicado: (2021) -
Anticoagulation therapy in COVID-19: Is there a dose-dependent benefit?
por: Kollias, Anastasios, et al.
Publicado: (2021) -
Statin use and mortality in COVID-19 patients: Updated systematic review and meta-analysis
por: Kollias, Anastasios, et al.
Publicado: (2021) -
Practical Recommendations for Optimal Thromboprophylaxis in Patients with COVID-19: A Consensus Statement Based on Available Clinical Trials
por: Kyriakoulis, Konstantinos G., et al.
Publicado: (2022) -
The Effect of Anakinra in Hospitalized Patients with COVID-19: An Updated Systematic Review and Meta-Analysis
por: Kyriakoulis, Konstantinos G., et al.
Publicado: (2021)